Sunday, November 8, 2026

USD/CNH Bullish Momentum With A 1% Jump In The Last 5 Sessions

USD/CNH Bullish Momentum With A 1% Jump In The Last 5 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.17% for the last 5 sessions. At 05:07 EST on Friday, 22 March, USD/CNH (USDCNH) is $7.27.

USD/CNH's yearly highs and lows, it's 0.683% up from its 52-week low and 0.059% down from its 52-week high.

News about

  • According to FXStreet on Friday, 22 March, "The USD/JPY pair might then build on its longer-term uptrend witnessed since January 2023.", "This, along with the prevalent risk-on environment, which tends to dent demand for the safe-haven JPY, favours the USD/JPY bulls. "
  • Usd/jpy analysis: uptrend gains strength - 21 March 2024. According to DailyForex on Thursday, 21 March, "Today, the USD/JPY pair will react to market and investor response to the Federal Reserve announcement, along with the release of the weekly US jobless claims and readings of the Philadelphia Industrial Index and the Purchasing Managers' Index for the manufacturing and services sectors in the United States.", "Despite the halt in gains for the US dollar following the Federal Reserve announcement, the overall upward trend for the USD/JPY pair remains intact. "
  • Usd/jpy enters boj intervention zone after rallying into 151.000s. According to FXStreet on Wednesday, 20 March, "The USD/JPY rallies to multi-year highs in the 151.000s on Wednesday on the back of broad-based US Dollar (USD) strength ahead of the Federal Reserve policy meetingand a "one and done" trade weakening the Japanese Yen (JPY).", "The USD/JPY has rallied back up to the level of previous multi-year highs in the 151.000s. "
  • Usd/jpy should head down to the 145.00 area and probably close to 140.00 later this year – ING. According to FXStreet on Wednesday, 20 March, "Our baseline view now sees USD/JPY perhaps trading around the 150.00-152.00 area as long as short-term US rates stay firm. ", "When they turn lower over the coming months, USD/JPY should head down to the 145.00 area and probably close to 140.00 later this year when the Fed easing cycle is in full swing (we look for 125 bps of Fed cuts this year)."
  • According to FXStreet on Wednesday, 20 March, "Apart from this, the risk-on mood continues to undermine the safe-haven JPY, which, along with the recent US Dollar (USD) strength, lifts the USD/JPY pair further beyond the 151.00 round-figure mark.", "A sustained break below, however, might prompt some technical selling and drag the USD/JPY pair back towards the 150.00 psychological mark. "

More news about USD/CNH (USDCNH).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com